Tag: drug-device products

bioequivalence combination products fixed-dose combinations drug-device products generic drugs

Bioequivalence of Combination Products: Special Testing Challenges

Bioequivalence testing for combination products faces unique challenges due to multi-component formulations, device interactions, and lack of standardized methods. Learn why these drugs are harder to genericize-and what’s being done to fix it.

February 26 2026